Gara Jalqabaatti › Obesity › Ohio

Qorannoo klinikaalii Obesity Ohio keessatti

Qorannoo 46 Obesity f Ohio keessatti hirmaatuu jiru.

Magaalota Ohio keessatti

Takkalaa qorannoo (Ingiliffa)

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Clinical Trial Investigator Clinical Research Center, Cincinnati
Velocity Clinical Research - Cincinnati, Cincinnati

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Velocity Clinical Research - Cincinnati, Cincinnati
Velocity Clinical Research - Springdale, Cincinnati

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684144

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Velocity Clinical Research - Cleveland, Beachwood
Aultman Hospital, Cardiovascular Consultants, Inc, Canton
Velocity Clinical Research - Auburn, Cincinnati
fi 2 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

CTI Clinical Research Center /ID# 282043, Cincinnati

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07752979

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Centricity Research - Ohio, Columbus
PriMed Clinical Research, Dayton

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 8 hanga 18 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07253285

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Velocity Clinical Research, Cincinnati, Springdale, Cincinnati

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07783802

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Midwest Eye Center, Cincinnati
Velocity Clinical Research, Mt. Auburn, Cincinnati

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07595549

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Ohio Clinical Trials, Columbus

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07399678

Comparing Reduction With ESD- Versus APC-TORe

Cleveland Clinic Foundation, Cleveland

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06131281

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Columbus

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07776509

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Cleveland Clinic, Cleveland
Nationwide Children's Hospital, Columbus

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

CTI Clinical Research Center, Cincinnati
Care Access - Lima, Lima

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Care Access - Lima, Lima

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07282600

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

CTI Clinical Research Center, Cincinnati

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

CTI Clinical Research Center, Cincinnati

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07369011

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Kent

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Cincinnati
AURORA-2 Clinical Site, Cleveland
AURORA-2 Clinical Site, Columbus
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Cincinnati
AURORA-1 Clinical Site, Cleveland
AURORA-1 Clinical Site, Columbus
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Remington Davis Inc, Columbus

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Providence Health Partners-Center for Clinical Research, Dayton

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Hometown Urgent Care and Research - Dayton, Dayton

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Columbus

Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo

Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07654374

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

CTI Clinical Research Center, Cincinnati

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07571005

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

CTI Clinical Research Center, Cincinnati

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07571109

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

PriMED Clinical Research, Dayton

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07215559

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

CTI Clinical Research Center, Cincinnati

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06143956

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Optima Research - Boardman, Boardman

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Cleveland

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07284901

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Columbus

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT07784725

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Cincinnati Children's Hospital Medical Center, Cincinnati

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 7 hanga 25 · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Aultman Hospital, Canton
Lindner Center,Christ Hospital, Cincinnati
Louis Stokes Clvlnd VA Med Ctr, Cleveland
fi 4 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Columbus
ACCOMPLISH-1 Research Site, Columbus

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07654361

Atomoxetine in Melanocortin Obesity Syndrome

Nationwide Children's Hospital, Columbus

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 6 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06899178

Fibrosis Lessens After Metabolic Surgery

Cleveland Clinic, Cleveland

Namoota walitti qabaa jiraSadarkaa 4Hojjettoota fayyaa simatamoo

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06374875

Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

The Ohio State University, Columbus

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07702461

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Ohio Clinical Trials, Columbus

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07477704

A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants

Medpace Clinical Pharmacology Unit, Cincinnati

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo

Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 04-Cam-2026 · NCT07219589

Dietary Peanuts and Nutrition-Related Outcomes

University Hospitals Cleveland Medical Center, Clevland

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo

Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 23-Elb-2026 · NCT07244458

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.